This is a news story, published by CNBC, that relates primarily to Pfizer news.
For more Pfizer news, you can click here:
more Pfizer newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Former Pfizer CEO Ian Read. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest activist investor Starboard Value news, Pfizer CEO Albert Bourla news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
former Pfizer executivesCNBC
•
72% Informative
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio say they are "fully supportive" of current CEO Albert Bourla .
Starboard Value has amassed a roughly $1 billion position in the company.
The about face comes as Pfizer 's board grapples with the activist's efforts.
VR Score
80
Informative language
84
Neutral language
38
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links